Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cellsFatmah R. Alsereidi, Mohamed A. Saleh, Zenith Khashim et al.|Cardiovascular Diabetology|2024Cited by 50
Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvementFatmah R. Alsereidi, Mohamed A. Saleh, Mahmoud M. Ramadan et al.|Current Problems in Cardiology|2024Cited by 40
The Association between β-Thalassemia Major (β-TM) and Cardiac Complications: Recent InsightsJalal Taneera, Mawieh Hamad, Amani Alhajji et al.|Current Cardiology Reviews|2025Cited by 0